Pathogenic effects of plasma thiols in patients with psoriasis on background of arterial hypertension

Authors

  • G. I. Makurina Zaporozhye State Medical University,

DOI:

https://doi.org/10.14739/2409-2932.2016.3.77997

Keywords:

Nitric Oxide, Thiol-Disulfide Balance, Psoriasis, Essential Hypertension

Abstract

Objective: to study the features of metabolism of nitric oxide and thiol-disulfide balance parameters in patients with psoriasis combined with essential hypertension.

Materials and metods. The study of thiol-disulfide balance and nitrogen metabolism were performed in 95 patients who were divided into 3 groups: Group I - psoriasis and hypertension - 25 people; II group - patients with psoriasis only - 30 and Group III - patients with hypertension only - 40 people. To assess psoriasis severity index we used Psoriasis Area and Severity Index (PASI). The level of reduced and oxidized glutathione in plasma was evaluated with fluorometric method with further calculating their ratio.

Results. In patients with hypertension status thiol-disulfide systems change were fairly minimal compared to a group of patients with psoriasis only and comorbid disorders. During examination the patients with combined pathology of psoriasis and essential  hypertension in the progressive phase of the disease revealed significant changes in glutathione systems and free-radical oxidation, characterized by a significantly decrease in the content of reduced glutathione (16,5±0,48 mmol/l) and increased content of oxidized glutathione (3,23±0,06 mol/l), while reducing the activity of the enzyme superoxide dismutase (24,21±1,44 conventional units /mg protein/min) and reduction ratio of the recovered / oxidized glutathione to 5,1±0,26 conventional units. In patients with psoriasis with increasing severity of thiol-disulfide balance violations we recorded a significant deterioration in the clinical situation and reduced quality of life. These changes characterize the progression of endothelial dysfunction in these patients.

Conclusion. Formation of psoriasis progression was significantly associated with low functional capacity glutathione link of antioxidant system and with the inability to adequately replenish the pool of reduced glutathione.

Since oxidative stress arises not only when the redundancy of reactive oxygen forms, but also in the failure of the antioxidant system, the state of protective enzymes in the pathologically altered skin epidermis in the dynamics of the process and the pathogenesis of essential hypertension may be potential therapeutic targets.

References

Chamcheu, J. C., Adhami, V. M., Esnault, S., Sechi, M., Siddiqui, I. A., Satyshur, K. A., et al. (2016) Dual inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant Delphinidin Ameliorates Psoriatic Features In-vitro and in an Imiquimod-induced Psoriasis-like Disease in Mice. Antioxid Redox Signal.

Grashin, P. A., Polyakova, A. B., & Telichko, I. N. (2011) Vozmozhnosti ispol'zovaniya pokazatelej pro- i antioksidantnoj sistem dlya ocenki stepeni tyazhesti i kharaktera techeniya psoriaza [The possibility of using indicators of pro- and antioxidant systems to assess the severity and nature of the flow in psoriasis]. Sankt-Peterburgskie dermatologicheskie chteniya Abstracts of Papers of the 5th Russian scientific-practical conference, (P. 43). Saint Petrsburg. [in Russian].

Herédi, E., Végh, J., Pogácsás, L., Gáspár, K., Varga, J., Kincse, G., et al. (2016) Subclinical cardiovascular disease and it's improvement after long-term TNF-α inhibitor therapy in severe psoriatic patients. J Eur Acad Dermatol Venereol. doi: 10.1111/jdv.13649.

Polyakova, A. B., Telichko, I. N., & Grashin, P. A. (2012) Pro- i antioksidantnye processy u bol'nykh vul'garnym psoriazom i ikh rol' v ocenke tyazhesti i haraktera techeniya bolezni [Pro- and antioxidant processes in patients with psoriasis vulgaris and their role in assessing the gravity and nature of the disease]. Abstracts of Papers of the second congress of the Euro-Asian Association of dermatologists, (Vol. 138). Moscow. [in Russian].

Masood, S., Sajid, S., Jafferani, A., Tabassum, S., & Ansar, S. (2014) Multiple autoimmune syndromes associated with psoriasis: a rare clinical presentation. Oman Med J., 29(2), 130-1. doi: 10.5001/omj.2014.31.

Armstrong, E. J., & Krueger, J. G. (2016) Lipoprotein Metabolism and Inflammation in Patients With Psoriasis. Am J Cardiol. doi: 10.1016/j.amjcard.2016.05.060.

Barakhovskaya, T. V., Verlan, N. V., & Kolesnichenko, L. S. (2010) Vozmozhnosti antioksidantnoj terapii pri poli-morbidnosti v geriatrii [Features of antioxidant therapy of polymorbidity in geriatrics] Prakticheskaya geriatriya. Proceedings of the Conference, (P. 17–19). Irkutsk. [in Russain].

Lyakhovich, V. V., Vavilin, V. A., Zenkov, N. K., & Menshchikova, E. B. (2006) Aktivnaya zashchita pri okislitel'nom stresse. Antioksidant-responsivnyj e´hlement [Active defense under oxidative stress. The antioxidant responsive element]. Biokhimiya, 71(9), 1183–1197. [in Russain].

Gui, J., Gober, M., Yang, X., Katlinski, K. V., Marshall, C. M., Sharma, M., et al. (2016) Therapeutic elimination of the type 1 interferon receptor for treating psoriatic skin inflammation. J Invest Dermatol. doi: 10.1016/j.jid.2016.06.608.

Kulinskij, V. I., & Kolesnichenko, L. S. (2009) Sistema glutationa I. Sintez, transport glutationtransferazy, glutationperoksidazy [The glutathione system. II. Other enzymes, thiol-disulfide metabolism, inflammation, and immunity, functions]. Biomedicinskaya khimiya, 55(3), 255–277. [in Russain].

Shrivastava, V. K., Londhe, N. D., Sonawane, R. S., & Suri, J. S. (2015) Exploring the color feature power for psoriasis risk stratification and classification: A data mining paradigm. Comput Biol Med., 65, 54–68. doi: 10.1016/j.compbiomed.2015.07.021.

Chesnokova, N. P., et al. (2008) O roli aktivacii svobodnoradikal'nogo okisleniya v strukturnoj i funkcional'noj dezorganizacii biosistem v usloviyakh patologii [The role of the activation of free radical oxidation in the structural and functional disorganization biosystems in terms of pathology]. Uspekhi sovremennogo estestvoznaniya, 128(3.1), 25–34. [in Russain].

Campa, M., Ryan, C., & Menter, A. (2015) An overview of developing TNF-α targeted therapy for the treatment of psoriasis. Expert Opin Investig Drugs., 24(10), 1343–54. doi: 10.1517/13543784.2015.1076793.

Men'shikova, E. B., Zenkov, N. K., Lankin, I V., Bondar', Z. A., & Trufakin, V. A. (2008) Okislitel'nyj stress. Patologicheskie sostoyaniya i zabolevaniya [Oxidative stress. Pathological conditions and diseases]. Novosibirsk: APTA. [in Russain].

Pang, X., Lin, K., Zhang, P., Liu, W., Zhang, P., & Zhu, S. (2015) Characterization of the abnormal lipid profile in Chinese patients with psoriasis. J Clin Exp Pathol., 8(11), 15280-4.

Shkolnikova, T. V., Zorina, V. N., Korotky, N. G., Zorina, R. M., Burdina, A. V., & Konyakhina, I. G. (2012) Belki ostroj fazy vospaleniya v syvorotke krovi bol'nykh psoriazom [Acute phase proteins in the sera of psoriasis patients]. Rossijskij zhurnal kozhnykh i venericheskikh boleznej, 6, 36–38. [in Russain].

Doncova, E. V. (2013) Sostoyanie sistemy perekisnogo okisleniya lipidov i antioksidantnoj zashchity krovi u bol'nyh psoriazom i metabolicheskim sindromom [System Status of lipid peroxidation and antioxidant protection in the blood of patients with psoriasis and the metabolic syndrome] Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Medicina. Farmaciya, 22(11), 95–98. [in Russian].

Davis, S. A., & Feldman, S. R. (2013) Combination therapy for psoriasis in the United States. J Drugs Dermatol., 12(5), 546–50.

Esposito, M., Gisondi, P., Cassano, N., Ferrucci, G., Del Giglio, M., Loconsole, F., et al. (2013) Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study. Br J Dermatol., 169(3), 666–72. doi: 10.1111/bjd.12422.

van den Reek, J. M., van Lüumig, P. P., Otero, M. E., Zweegers, J., van de Kerkhof, P. C., Ossenkoppele, P. M., et al. (2014) Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network. Br J Dermatol., 170(5), 1158–65. doi: 10.1111/bjd.12862.

Twiss, J., & McKenna, S. P. (2015) Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD. Qual Life Res., 24(1), 105–13. doi: 10.1007/s11136-014-0630-y.

How to Cite

1.
Makurina GI. Pathogenic effects of plasma thiols in patients with psoriasis on background of arterial hypertension. Current issues in pharmacy and medicine: science and practice [Internet]. 2016Sep.22 [cited 2024Jul.13];9(3). Available from: http://pharmed.zsmu.edu.ua/article/view/77997

Issue

Section

Original research